Skip to main content
MedVellum
MCQsExamsAtlas
DashboardPricing
MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳

MedVellum.

The folio

Exam-exhaustive medical education across every specialty — evidence-graded topics, engraved plates, and practice in every written and oral format. Educational content only — not medical advice.

llms.txt · psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship
  • Paediatrics Fellowship
  • Physician Medicine

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Folio edition · Set in Instrument Serif & Archivo

Paeds Casesallergy-and-immunology

Paeds Cases · allergy-and-immunology

Counsel a family on rituximab-related secondary hypogammaglobulinaemia and prophylaxis — OSCE

OSCE communication and shared-planning station: explaining secondary immunodeficiency arising from a biologic (rituximab) given for nephrotic syndrome, why immunoglobulin replacement is driven by infection burden rather than a single low number, the role of antimicrobial prophylaxis and safe vaccination, and the generally good prognosis with consistent follow-up — while addressing fear and avoiding the over-treatment trap.

osce communication and shared decision-making
On this page & tools

Target exams

MRCPCH ClinicalRACP DCERCPSC Pediatrics

Target exams

MRCPCH ClinicalRACP DCERCPSC Pediatrics
Prompt
The parents of a six-year-old girl treated with rituximab for frequently-relapsing nephrotic syndrome have been told her immunoglobulins are now low and she has had two chest infections in three months. They are frightened the treatment has 'destroyed her immune system', worried that she will need immunoglobulin for life, and confused about what 'secondary immunodeficiency' means. They have read online that low antibodies can be permanent. Counsel them.

Candidate brief

You have eight minutes to counsel the parents of a six-year-old girl whose immunoglobulins have fallen after rituximab for nephrotic syndrome and who has had recent chest infections. The secondary immunodeficiency is iatrogenic and may be reversible. Use a structured, honest, empathic approach. [2] [1]

Key teaching and communication objectives

Acknowledge and validate the parents' fear before delivering information. Explain that "secondary immunodeficiency" means her immunity has been temporarily affected by a treatment, not that she was born with a permanent immune condition, and that the affected cells usually recover over many months. [2] [3]

Explain the next steps in plain language: confirm whether the low level is causing real infection susceptibility with a functional vaccine response and a careful infection history, because immunoglobulin replacement is decided by infection burden, not by the number alone. Address the online concern honestly: some forms of low antibody are permanent, but rituximab-related depletion usually recovers as B cells return, so a lifelong commitment is not assumed. [1] [3]

Describe the protection plan: prompt treatment of any new infection, consideration of antibiotic prophylaxis if infections continue, and safe vaccination (she can have her routine inactivated vaccines, but live vaccines are held while her immunity is suppressed, and her household contacts stay fully up to date). [1]

Close with a shared plan and a clear next appointment, framed around surveillance as her B cells recover, and an offer of written information and contact with a patient-support organisation. [2]

References

  1. [1]Otani IM, Lehman HK, Jongco AM, et al. Practical guidance for the diagnosis and management of secondary hypogammaglobulinemia: A Work Group Report. J Allergy Clin Immunol, 2022.PMID 35176351
  2. [2]Chan EY, Yap DY, Colucci M, et al. Use of Rituximab in Childhood Idiopathic Nephrotic Syndrome. Clin J Am Soc Nephrol, 2023.PMID 36456193
  3. [3]Chinen J, Shearer WT. Secondary immunodeficiencies, including HIV infection. J Allergy Clin Immunol, 2010.PMID 20042227